nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS2—melanoma	0.417	1	CbGaD
Nabumetone—CYP1A2—Carmustine—melanoma	0.131	0.417	CbGbCtD
Nabumetone—CYP1A2—Vemurafenib—melanoma	0.104	0.33	CbGbCtD
Nabumetone—CYP1A2—Dacarbazine—melanoma	0.0795	0.253	CbGbCtD
Nabumetone—MPO—endothelium—melanoma	0.00341	0.113	CbGeAlD
Nabumetone—PTGS2—leg—melanoma	0.00334	0.111	CbGeAlD
Nabumetone—MPO—blood vessel—melanoma	0.00314	0.104	CbGeAlD
Nabumetone—PTGS2—hindlimb—melanoma	0.00299	0.0989	CbGeAlD
Nabumetone—PTGS2—appendage—melanoma	0.00256	0.0848	CbGeAlD
Nabumetone—PTGS2—skin epidermis—melanoma	0.00213	0.0705	CbGeAlD
Nabumetone—PTGS1—endothelium—melanoma	0.00162	0.0536	CbGeAlD
Nabumetone—PTGS2—endothelium—melanoma	0.00155	0.0512	CbGeAlD
Nabumetone—PTGS1—blood vessel—melanoma	0.00149	0.0494	CbGeAlD
Nabumetone—MPO—skin of body—melanoma	0.00146	0.0482	CbGeAlD
Nabumetone—PTGS2—blood vessel—melanoma	0.00143	0.0472	CbGeAlD
Nabumetone—Melatonin—CYP1B1—melanoma	0.001	0.574	CrCbGaD
Nabumetone—MPO—head—melanoma	0.00095	0.0314	CbGeAlD
Nabumetone—Gastroenteritis—Temozolomide—melanoma	0.000937	0.00609	CcSEcCtD
Nabumetone—Hepatic failure—Temozolomide—melanoma	0.000924	0.00601	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000859	0.00559	CcSEcCtD
Nabumetone—Cough—Vemurafenib—melanoma	0.000854	0.00555	CcSEcCtD
Nabumetone—Liver function test abnormal—Dactinomycin—melanoma	0.000848	0.00551	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000827	0.00538	CcSEcCtD
Nabumetone—Anaphylactic shock—Vemurafenib—melanoma	0.000799	0.00519	CcSEcCtD
Nabumetone—Dysphagia—Dactinomycin—melanoma	0.000794	0.00516	CcSEcCtD
Nabumetone—Liver function test abnormal—Carmustine—melanoma	0.000793	0.00516	CcSEcCtD
Nabumetone—Hypokalaemia—Carmustine—melanoma	0.000782	0.00509	CcSEcCtD
Nabumetone—Weight decreased—Bleomycin—melanoma	0.00077	0.00501	CcSEcCtD
Nabumetone—Pneumonia—Bleomycin—melanoma	0.000763	0.00496	CcSEcCtD
Nabumetone—Hypokalaemia—Temozolomide—melanoma	0.000756	0.00492	CcSEcCtD
Nabumetone—Acute coronary syndrome—Bleomycin—melanoma	0.000748	0.00486	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000748	0.00486	CcSEcCtD
Nabumetone—Myocardial infarction—Bleomycin—melanoma	0.000744	0.00484	CcSEcCtD
Nabumetone—Dysphagia—Carmustine—melanoma	0.000743	0.00483	CcSEcCtD
Nabumetone—Stomatitis—Bleomycin—melanoma	0.00074	0.00481	CcSEcCtD
Nabumetone—Haematuria—Bleomycin—melanoma	0.000723	0.00471	CcSEcCtD
Nabumetone—Dysphagia—Temozolomide—melanoma	0.000718	0.00467	CcSEcCtD
Nabumetone—Pneumonia—Dactinomycin—melanoma	0.000712	0.00463	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000702	0.00456	CcSEcCtD
Nabumetone—Sweating increased—Temozolomide—melanoma	0.000699	0.00455	CcSEcCtD
Nabumetone—Decreased appetite—Vemurafenib—melanoma	0.000694	0.00452	CcSEcCtD
Nabumetone—PTGS1—skin of body—melanoma	0.000691	0.0229	CbGeAlD
Nabumetone—Stomatitis—Dactinomycin—melanoma	0.00069	0.00449	CcSEcCtD
Nabumetone—Fatigue—Vemurafenib—melanoma	0.000689	0.00448	CcSEcCtD
Nabumetone—Haemoglobin—Bleomycin—melanoma	0.000685	0.00445	CcSEcCtD
Nabumetone—Constipation—Vemurafenib—melanoma	0.000683	0.00444	CcSEcCtD
Nabumetone—Haemorrhage—Bleomycin—melanoma	0.000681	0.00443	CcSEcCtD
Nabumetone—Dysuria—Temozolomide—melanoma	0.000671	0.00437	CcSEcCtD
Nabumetone—Hyperglycaemia—Carmustine—melanoma	0.00067	0.00436	CcSEcCtD
Nabumetone—Pneumonia—Carmustine—melanoma	0.000666	0.00433	CcSEcCtD
Nabumetone—MPO—lymph node—melanoma	0.000665	0.022	CbGeAlD
Nabumetone—Erectile dysfunction—Temozolomide—melanoma	0.000661	0.0043	CcSEcCtD
Nabumetone—Depression—Carmustine—melanoma	0.00066	0.0043	CcSEcCtD
Nabumetone—Agranulocytosis—Dactinomycin—melanoma	0.00066	0.00429	CcSEcCtD
Nabumetone—PTGS2—skin of body—melanoma	0.00066	0.0219	CbGeAlD
Nabumetone—Photosensitivity reaction—Temozolomide—melanoma	0.000655	0.00426	CcSEcCtD
Nabumetone—Weight increased—Temozolomide—melanoma	0.000653	0.00425	CcSEcCtD
Nabumetone—Renal failure—Carmustine—melanoma	0.000651	0.00423	CcSEcCtD
Nabumetone—Weight decreased—Temozolomide—melanoma	0.000649	0.00422	CcSEcCtD
Nabumetone—Hyperglycaemia—Temozolomide—melanoma	0.000647	0.00421	CcSEcCtD
Nabumetone—Stomatitis—Carmustine—melanoma	0.000646	0.0042	CcSEcCtD
Nabumetone—Pneumonia—Temozolomide—melanoma	0.000644	0.00419	CcSEcCtD
Nabumetone—Depression—Temozolomide—melanoma	0.000638	0.00415	CcSEcCtD
Nabumetone—Thrombophlebitis—Docetaxel—melanoma	0.000638	0.00415	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000634	0.00413	CcSEcCtD
Nabumetone—Body temperature increased—Vemurafenib—melanoma	0.000631	0.00411	CcSEcCtD
Nabumetone—PTGS1—mammalian vulva—melanoma	0.00063	0.0209	CbGeAlD
Nabumetone—Stomatitis—Temozolomide—melanoma	0.000624	0.00406	CcSEcCtD
Nabumetone—Hepatic failure—Docetaxel—melanoma	0.000615	0.004	CcSEcCtD
Nabumetone—Chills—Bleomycin—melanoma	0.000611	0.00397	CcSEcCtD
Nabumetone—Alopecia—Bleomycin—melanoma	0.000602	0.00391	CcSEcCtD
Nabumetone—Erythema multiforme—Dactinomycin—melanoma	0.000601	0.00391	CcSEcCtD
Nabumetone—Haemoglobin—Carmustine—melanoma	0.000598	0.00389	CcSEcCtD
Nabumetone—Haemorrhage—Carmustine—melanoma	0.000595	0.00387	CcSEcCtD
Nabumetone—Hypersensitivity—Vemurafenib—melanoma	0.000588	0.00383	CcSEcCtD
Nabumetone—Dermatitis bullous—Docetaxel—melanoma	0.000578	0.00376	CcSEcCtD
Nabumetone—Haemoglobin—Temozolomide—melanoma	0.000577	0.00376	CcSEcCtD
Nabumetone—Haemorrhage—Temozolomide—melanoma	0.000575	0.00374	CcSEcCtD
Nabumetone—Asthenia—Vemurafenib—melanoma	0.000573	0.00373	CcSEcCtD
Nabumetone—Visual impairment—Carmustine—melanoma	0.000573	0.00373	CcSEcCtD
Nabumetone—Chills—Dactinomycin—melanoma	0.00057	0.00371	CcSEcCtD
Nabumetone—Pruritus—Vemurafenib—melanoma	0.000565	0.00368	CcSEcCtD
Nabumetone—Alopecia—Dactinomycin—melanoma	0.000561	0.00365	CcSEcCtD
Nabumetone—Visual impairment—Temozolomide—melanoma	0.000554	0.0036	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000552	0.00359	CcSEcCtD
Nabumetone—Ill-defined disorder—Bleomycin—melanoma	0.00055	0.00358	CcSEcCtD
Nabumetone—Anaemia—Bleomycin—melanoma	0.000548	0.00356	CcSEcCtD
Nabumetone—Diarrhoea—Vemurafenib—melanoma	0.000546	0.00355	CcSEcCtD
Nabumetone—Erythema multiforme—Temozolomide—melanoma	0.000543	0.00353	CcSEcCtD
Nabumetone—Tinnitus—Temozolomide—melanoma	0.000536	0.00348	CcSEcCtD
Nabumetone—Malaise—Bleomycin—melanoma	0.000535	0.00348	CcSEcCtD
Nabumetone—Arrhythmia—Carmustine—melanoma	0.000531	0.00345	CcSEcCtD
Nabumetone—Leukopenia—Bleomycin—melanoma	0.000531	0.00345	CcSEcCtD
Nabumetone—Dizziness—Vemurafenib—melanoma	0.000528	0.00344	CcSEcCtD
Nabumetone—Alopecia—Carmustine—melanoma	0.000525	0.00342	CcSEcCtD
Nabumetone—Cough—Bleomycin—melanoma	0.000517	0.00337	CcSEcCtD
Nabumetone—Chills—Temozolomide—melanoma	0.000515	0.00335	CcSEcCtD
Nabumetone—Ill-defined disorder—Dactinomycin—melanoma	0.000513	0.00334	CcSEcCtD
Nabumetone—Anaemia—Dactinomycin—melanoma	0.000511	0.00332	CcSEcCtD
Nabumetone—Liver function test abnormal—Docetaxel—melanoma	0.00051	0.00332	CcSEcCtD
Nabumetone—Vomiting—Vemurafenib—melanoma	0.000508	0.0033	CcSEcCtD
Nabumetone—Alopecia—Temozolomide—melanoma	0.000508	0.0033	CcSEcCtD
Nabumetone—Rash—Vemurafenib—melanoma	0.000504	0.00328	CcSEcCtD
Nabumetone—Dermatitis—Vemurafenib—melanoma	0.000503	0.00327	CcSEcCtD
Nabumetone—Headache—Vemurafenib—melanoma	0.0005	0.00325	CcSEcCtD
Nabumetone—Discomfort—Bleomycin—melanoma	0.000499	0.00324	CcSEcCtD
Nabumetone—Malaise—Dactinomycin—melanoma	0.000499	0.00324	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000497	0.00323	CcSEcCtD
Nabumetone—Leukopenia—Dactinomycin—melanoma	0.000495	0.00322	CcSEcCtD
Nabumetone—Confusional state—Bleomycin—melanoma	0.000488	0.00317	CcSEcCtD
Nabumetone—Tremor—Carmustine—melanoma	0.000485	0.00315	CcSEcCtD
Nabumetone—Anaphylactic shock—Bleomycin—melanoma	0.000484	0.00315	CcSEcCtD
Nabumetone—Oedema—Bleomycin—melanoma	0.000484	0.00315	CcSEcCtD
Nabumetone—Anaemia—Carmustine—melanoma	0.000478	0.00311	CcSEcCtD
Nabumetone—Dysphagia—Docetaxel—melanoma	0.000477	0.0031	CcSEcCtD
Nabumetone—Agitation—Carmustine—melanoma	0.000476	0.00309	CcSEcCtD
Nabumetone—Nausea—Vemurafenib—melanoma	0.000474	0.00309	CcSEcCtD
Nabumetone—Thrombocytopenia—Bleomycin—melanoma	0.000474	0.00308	CcSEcCtD
Nabumetone—Tremor—Temozolomide—melanoma	0.000469	0.00305	CcSEcCtD
Nabumetone—Discomfort—Dactinomycin—melanoma	0.000465	0.00303	CcSEcCtD
Nabumetone—Angina pectoris—Docetaxel—melanoma	0.000465	0.00302	CcSEcCtD
Nabumetone—Ill-defined disorder—Temozolomide—melanoma	0.000464	0.00302	CcSEcCtD
Nabumetone—Leukopenia—Carmustine—melanoma	0.000463	0.00301	CcSEcCtD
Nabumetone—Anaemia—Temozolomide—melanoma	0.000462	0.00301	CcSEcCtD
Nabumetone—Anorexia—Bleomycin—melanoma	0.000461	0.003	CcSEcCtD
Nabumetone—Agitation—Temozolomide—melanoma	0.00046	0.00299	CcSEcCtD
Nabumetone—Angioedema—Temozolomide—melanoma	0.000457	0.00297	CcSEcCtD
Nabumetone—Oedema—Dactinomycin—melanoma	0.000451	0.00294	CcSEcCtD
Nabumetone—Malaise—Temozolomide—melanoma	0.000451	0.00293	CcSEcCtD
Nabumetone—PTGS1—head—melanoma	0.000451	0.0149	CbGeAlD
Nabumetone—Vertigo—Temozolomide—melanoma	0.000449	0.00292	CcSEcCtD
Nabumetone—Leukopenia—Temozolomide—melanoma	0.000448	0.00291	CcSEcCtD
Nabumetone—Hypertension—Carmustine—melanoma	0.000447	0.00291	CcSEcCtD
Nabumetone—Palpitations—Temozolomide—melanoma	0.000442	0.00287	CcSEcCtD
Nabumetone—Thrombocytopenia—Dactinomycin—melanoma	0.000442	0.00287	CcSEcCtD
Nabumetone—Anxiety—Carmustine—melanoma	0.000439	0.00286	CcSEcCtD
Nabumetone—Cough—Temozolomide—melanoma	0.000436	0.00284	CcSEcCtD
Nabumetone—Paraesthesia—Bleomycin—melanoma	0.000434	0.00283	CcSEcCtD
Nabumetone—Weight increased—Docetaxel—melanoma	0.000434	0.00283	CcSEcCtD
Nabumetone—Weight decreased—Docetaxel—melanoma	0.000432	0.00281	CcSEcCtD
Nabumetone—Hypertension—Temozolomide—melanoma	0.000432	0.00281	CcSEcCtD
Nabumetone—Dyspnoea—Bleomycin—melanoma	0.000431	0.00281	CcSEcCtD
Nabumetone—PTGS2—head—melanoma	0.000431	0.0143	CbGeAlD
Nabumetone—Anorexia—Dactinomycin—melanoma	0.00043	0.0028	CcSEcCtD
Nabumetone—Pneumonia—Docetaxel—melanoma	0.000428	0.00278	CcSEcCtD
Nabumetone—Confusional state—Carmustine—melanoma	0.000426	0.00277	CcSEcCtD
Nabumetone—Anxiety—Temozolomide—melanoma	0.000424	0.00276	CcSEcCtD
Nabumetone—Oedema—Carmustine—melanoma	0.000422	0.00275	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000422	0.00274	CcSEcCtD
Nabumetone—Discomfort—Temozolomide—melanoma	0.000421	0.00274	CcSEcCtD
Nabumetone—Decreased appetite—Bleomycin—melanoma	0.000421	0.00274	CcSEcCtD
Nabumetone—Acute coronary syndrome—Docetaxel—melanoma	0.00042	0.00273	CcSEcCtD
Nabumetone—Renal failure—Docetaxel—melanoma	0.000418	0.00272	CcSEcCtD
Nabumetone—Myocardial infarction—Docetaxel—melanoma	0.000417	0.00271	CcSEcCtD
Nabumetone—Dry mouth—Temozolomide—melanoma	0.000416	0.00271	CcSEcCtD
Nabumetone—Stomatitis—Docetaxel—melanoma	0.000415	0.0027	CcSEcCtD
Nabumetone—Jaundice—Docetaxel—melanoma	0.000415	0.0027	CcSEcCtD
Nabumetone—Thrombocytopenia—Carmustine—melanoma	0.000414	0.00269	CcSEcCtD
Nabumetone—Confusional state—Temozolomide—melanoma	0.000412	0.00268	CcSEcCtD
Nabumetone—Anaphylactic shock—Temozolomide—melanoma	0.000408	0.00265	CcSEcCtD
Nabumetone—Oedema—Temozolomide—melanoma	0.000408	0.00265	CcSEcCtD
Nabumetone—Anorexia—Carmustine—melanoma	0.000403	0.00262	CcSEcCtD
Nabumetone—Thrombocytopenia—Temozolomide—melanoma	0.0004	0.0026	CcSEcCtD
Nabumetone—Feeling abnormal—Bleomycin—melanoma	0.000399	0.00259	CcSEcCtD
Nabumetone—Agranulocytosis—Docetaxel—melanoma	0.000397	0.00258	CcSEcCtD
Nabumetone—Hyperhidrosis—Temozolomide—melanoma	0.000395	0.00257	CcSEcCtD
Nabumetone—Naproxen—PTGS2—melanoma	0.000393	0.225	CrCbGaD
Nabumetone—Decreased appetite—Dactinomycin—melanoma	0.000392	0.00255	CcSEcCtD
Nabumetone—Fatigue—Dactinomycin—melanoma	0.000389	0.00253	CcSEcCtD
Nabumetone—Anorexia—Temozolomide—melanoma	0.000389	0.00253	CcSEcCtD
Nabumetone—Urticaria—Bleomycin—melanoma	0.000384	0.0025	CcSEcCtD
Nabumetone—Haemoglobin—Docetaxel—melanoma	0.000384	0.0025	CcSEcCtD
Nabumetone—Body temperature increased—Bleomycin—melanoma	0.000383	0.00249	CcSEcCtD
Nabumetone—Haemorrhage—Docetaxel—melanoma	0.000382	0.00249	CcSEcCtD
Nabumetone—Insomnia—Carmustine—melanoma	0.000382	0.00248	CcSEcCtD
Nabumetone—Paraesthesia—Carmustine—melanoma	0.000379	0.00247	CcSEcCtD
Nabumetone—Dyspnoea—Carmustine—melanoma	0.000377	0.00245	CcSEcCtD
Nabumetone—Somnolence—Carmustine—melanoma	0.000375	0.00244	CcSEcCtD
Nabumetone—Feeling abnormal—Dactinomycin—melanoma	0.000372	0.00242	CcSEcCtD
Nabumetone—Insomnia—Temozolomide—melanoma	0.000369	0.0024	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dactinomycin—melanoma	0.000369	0.0024	CcSEcCtD
Nabumetone—Visual impairment—Docetaxel—melanoma	0.000368	0.00239	CcSEcCtD
Nabumetone—Decreased appetite—Carmustine—melanoma	0.000367	0.00239	CcSEcCtD
Nabumetone—Paraesthesia—Temozolomide—melanoma	0.000367	0.00238	CcSEcCtD
Nabumetone—Dyspnoea—Temozolomide—melanoma	0.000364	0.00237	CcSEcCtD
Nabumetone—Somnolence—Temozolomide—melanoma	0.000363	0.00236	CcSEcCtD
Nabumetone—Erythema multiforme—Docetaxel—melanoma	0.000361	0.00235	CcSEcCtD
Nabumetone—Constipation—Carmustine—melanoma	0.000361	0.00235	CcSEcCtD
Nabumetone—Dyspepsia—Temozolomide—melanoma	0.000359	0.00234	CcSEcCtD
Nabumetone—Abdominal pain—Dactinomycin—melanoma	0.000357	0.00232	CcSEcCtD
Nabumetone—Body temperature increased—Dactinomycin—melanoma	0.000357	0.00232	CcSEcCtD
Nabumetone—Hypersensitivity—Bleomycin—melanoma	0.000357	0.00232	CcSEcCtD
Nabumetone—Decreased appetite—Temozolomide—melanoma	0.000355	0.00231	CcSEcCtD
Nabumetone—Fatigue—Temozolomide—melanoma	0.000352	0.00229	CcSEcCtD
Nabumetone—Naproxen—ALB—melanoma	0.00035	0.201	CrCbGaD
Nabumetone—Constipation—Temozolomide—melanoma	0.000349	0.00227	CcSEcCtD
Nabumetone—Feeling abnormal—Carmustine—melanoma	0.000348	0.00226	CcSEcCtD
Nabumetone—Asthenia—Bleomycin—melanoma	0.000347	0.00226	CcSEcCtD
Nabumetone—Gastrointestinal pain—Carmustine—melanoma	0.000345	0.00225	CcSEcCtD
Nabumetone—Chills—Docetaxel—melanoma	0.000343	0.00223	CcSEcCtD
Nabumetone—Pruritus—Bleomycin—melanoma	0.000342	0.00223	CcSEcCtD
Nabumetone—Arrhythmia—Docetaxel—melanoma	0.000341	0.00222	CcSEcCtD
Nabumetone—Alopecia—Docetaxel—melanoma	0.000338	0.0022	CcSEcCtD
Nabumetone—Feeling abnormal—Temozolomide—melanoma	0.000336	0.00219	CcSEcCtD
Nabumetone—Abdominal pain—Carmustine—melanoma	0.000334	0.00217	CcSEcCtD
Nabumetone—Body temperature increased—Carmustine—melanoma	0.000334	0.00217	CcSEcCtD
Nabumetone—Gastrointestinal pain—Temozolomide—melanoma	0.000334	0.00217	CcSEcCtD
Nabumetone—Hypersensitivity—Dactinomycin—melanoma	0.000332	0.00216	CcSEcCtD
Nabumetone—Urticaria—Temozolomide—melanoma	0.000324	0.00211	CcSEcCtD
Nabumetone—Asthenia—Dactinomycin—melanoma	0.000324	0.00211	CcSEcCtD
Nabumetone—Abdominal pain—Temozolomide—melanoma	0.000323	0.0021	CcSEcCtD
Nabumetone—Body temperature increased—Temozolomide—melanoma	0.000323	0.0021	CcSEcCtD
Nabumetone—PTGS1—lymph node—melanoma	0.000316	0.0104	CbGeAlD
Nabumetone—Hypersensitivity—Carmustine—melanoma	0.000311	0.00202	CcSEcCtD
Nabumetone—Diarrhoea—Dactinomycin—melanoma	0.000309	0.00201	CcSEcCtD
Nabumetone—Vomiting—Bleomycin—melanoma	0.000308	0.002	CcSEcCtD
Nabumetone—Anaemia—Docetaxel—melanoma	0.000307	0.002	CcSEcCtD
Nabumetone—Rash—Bleomycin—melanoma	0.000305	0.00198	CcSEcCtD
Nabumetone—Dermatitis—Bleomycin—melanoma	0.000305	0.00198	CcSEcCtD
Nabumetone—Asthenia—Carmustine—melanoma	0.000303	0.00197	CcSEcCtD
Nabumetone—PTGS2—lymph node—melanoma	0.000302	0.00998	CbGeAlD
Nabumetone—Hypersensitivity—Temozolomide—melanoma	0.000301	0.00196	CcSEcCtD
Nabumetone—Syncope—Docetaxel—melanoma	0.000298	0.00194	CcSEcCtD
Nabumetone—Leukopenia—Docetaxel—melanoma	0.000298	0.00194	CcSEcCtD
Nabumetone—Palpitations—Docetaxel—melanoma	0.000294	0.00191	CcSEcCtD
Nabumetone—Asthenia—Temozolomide—melanoma	0.000293	0.0019	CcSEcCtD
Nabumetone—Loss of consciousness—Docetaxel—melanoma	0.000292	0.0019	CcSEcCtD
Nabumetone—Cough—Docetaxel—melanoma	0.00029	0.00189	CcSEcCtD
Nabumetone—Diarrhoea—Carmustine—melanoma	0.000289	0.00188	CcSEcCtD
Nabumetone—Pruritus—Temozolomide—melanoma	0.000289	0.00188	CcSEcCtD
Nabumetone—Nausea—Bleomycin—melanoma	0.000287	0.00187	CcSEcCtD
Nabumetone—Hypertension—Docetaxel—melanoma	0.000287	0.00187	CcSEcCtD
Nabumetone—Vomiting—Dactinomycin—melanoma	0.000287	0.00187	CcSEcCtD
Nabumetone—Rash—Dactinomycin—melanoma	0.000285	0.00185	CcSEcCtD
Nabumetone—Dizziness—Carmustine—melanoma	0.000279	0.00182	CcSEcCtD
Nabumetone—Diarrhoea—Temozolomide—melanoma	0.000279	0.00182	CcSEcCtD
Nabumetone—Dry mouth—Docetaxel—melanoma	0.000277	0.0018	CcSEcCtD
Nabumetone—Confusional state—Docetaxel—melanoma	0.000274	0.00178	CcSEcCtD
Nabumetone—Anaphylactic shock—Docetaxel—melanoma	0.000271	0.00177	CcSEcCtD
Nabumetone—Oedema—Docetaxel—melanoma	0.000271	0.00177	CcSEcCtD
Nabumetone—Dizziness—Temozolomide—melanoma	0.00027	0.00176	CcSEcCtD
Nabumetone—Vomiting—Carmustine—melanoma	0.000269	0.00175	CcSEcCtD
Nabumetone—Nausea—Dactinomycin—melanoma	0.000268	0.00174	CcSEcCtD
Nabumetone—Shock—Docetaxel—melanoma	0.000267	0.00174	CcSEcCtD
Nabumetone—Rash—Carmustine—melanoma	0.000266	0.00173	CcSEcCtD
Nabumetone—Dermatitis—Carmustine—melanoma	0.000266	0.00173	CcSEcCtD
Nabumetone—Thrombocytopenia—Docetaxel—melanoma	0.000266	0.00173	CcSEcCtD
Nabumetone—Headache—Carmustine—melanoma	0.000265	0.00172	CcSEcCtD
Nabumetone—Vomiting—Temozolomide—melanoma	0.00026	0.00169	CcSEcCtD
Nabumetone—Anorexia—Docetaxel—melanoma	0.000259	0.00168	CcSEcCtD
Nabumetone—Rash—Temozolomide—melanoma	0.000257	0.00167	CcSEcCtD
Nabumetone—Dermatitis—Temozolomide—melanoma	0.000257	0.00167	CcSEcCtD
Nabumetone—Headache—Temozolomide—melanoma	0.000256	0.00166	CcSEcCtD
Nabumetone—Nausea—Carmustine—melanoma	0.000251	0.00163	CcSEcCtD
Nabumetone—Insomnia—Docetaxel—melanoma	0.000246	0.0016	CcSEcCtD
Nabumetone—Paraesthesia—Docetaxel—melanoma	0.000244	0.00159	CcSEcCtD
Nabumetone—Nausea—Temozolomide—melanoma	0.000242	0.00158	CcSEcCtD
Nabumetone—Dyspnoea—Docetaxel—melanoma	0.000242	0.00157	CcSEcCtD
Nabumetone—Somnolence—Docetaxel—melanoma	0.000241	0.00157	CcSEcCtD
Nabumetone—Dyspepsia—Docetaxel—melanoma	0.000239	0.00155	CcSEcCtD
Nabumetone—Decreased appetite—Docetaxel—melanoma	0.000236	0.00153	CcSEcCtD
Nabumetone—Fatigue—Docetaxel—melanoma	0.000234	0.00152	CcSEcCtD
Nabumetone—Constipation—Docetaxel—melanoma	0.000232	0.00151	CcSEcCtD
Nabumetone—Feeling abnormal—Docetaxel—melanoma	0.000224	0.00145	CcSEcCtD
Nabumetone—Gastrointestinal pain—Docetaxel—melanoma	0.000222	0.00144	CcSEcCtD
Nabumetone—Abdominal pain—Docetaxel—melanoma	0.000215	0.0014	CcSEcCtD
Nabumetone—Body temperature increased—Docetaxel—melanoma	0.000215	0.0014	CcSEcCtD
Nabumetone—Hypersensitivity—Docetaxel—melanoma	0.0002	0.0013	CcSEcCtD
Nabumetone—Asthenia—Docetaxel—melanoma	0.000195	0.00127	CcSEcCtD
Nabumetone—Pruritus—Docetaxel—melanoma	0.000192	0.00125	CcSEcCtD
Nabumetone—Diarrhoea—Docetaxel—melanoma	0.000186	0.00121	CcSEcCtD
Nabumetone—Dizziness—Docetaxel—melanoma	0.000179	0.00117	CcSEcCtD
Nabumetone—Vomiting—Docetaxel—melanoma	0.000173	0.00112	CcSEcCtD
Nabumetone—Rash—Docetaxel—melanoma	0.000171	0.00111	CcSEcCtD
Nabumetone—Dermatitis—Docetaxel—melanoma	0.000171	0.00111	CcSEcCtD
Nabumetone—Headache—Docetaxel—melanoma	0.00017	0.00111	CcSEcCtD
Nabumetone—Nausea—Docetaxel—melanoma	0.000161	0.00105	CcSEcCtD
Nabumetone—PTGS2—Metabolism—HS3ST5—melanoma	6.41e-05	0.000779	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP1B1—melanoma	6.4e-05	0.000778	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CASP3—melanoma	6.4e-05	0.000777	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—melanoma	6.39e-05	0.000776	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	6.32e-05	0.000767	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CCND1—melanoma	6.23e-05	0.000757	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	6.18e-05	0.00075	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLCB4—melanoma	6.12e-05	0.000744	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	6.11e-05	0.000742	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—KRAS—melanoma	6.06e-05	0.000736	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MMP9—melanoma	6.05e-05	0.000735	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—FASN—melanoma	6.01e-05	0.00073	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	6.01e-05	0.00073	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—melanoma	5.98e-05	0.000727	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—melanoma	5.89e-05	0.000715	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	5.88e-05	0.000714	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	5.88e-05	0.000714	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	5.88e-05	0.000714	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	5.81e-05	0.000705	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC6A11—melanoma	5.76e-05	0.000699	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIP4K2A—melanoma	5.76e-05	0.000699	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	5.75e-05	0.000699	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	5.66e-05	0.000687	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTAP—melanoma	5.6e-05	0.00068	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	5.6e-05	0.00068	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	5.6e-05	0.00068	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	5.55e-05	0.000674	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.47e-05	0.000665	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	5.47e-05	0.000664	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CUL3—melanoma	5.46e-05	0.000663	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TRRAP—melanoma	5.46e-05	0.000663	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKR1B10—melanoma	5.31e-05	0.000645	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	5.2e-05	0.000632	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.16e-05	0.000627	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—HRAS—melanoma	5.15e-05	0.000626	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MAPK3—melanoma	5.14e-05	0.000624	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MYC—melanoma	5e-05	0.000607	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LUM—melanoma	4.99e-05	0.000606	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PHGDH—melanoma	4.99e-05	0.000606	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	4.94e-05	0.0006	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HPSE—melanoma	4.89e-05	0.000595	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MAPK1—melanoma	4.89e-05	0.000594	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—EGFR—melanoma	4.89e-05	0.000594	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	4.86e-05	0.000591	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLCB4—melanoma	4.86e-05	0.00059	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	4.85e-05	0.000589	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CUBN—melanoma	4.8e-05	0.000584	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	4.8e-05	0.000583	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	4.77e-05	0.00058	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—melanoma	4.75e-05	0.000577	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LUM—melanoma	4.73e-05	0.000575	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	4.72e-05	0.000573	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—melanoma	4.65e-05	0.000565	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SDHD—melanoma	4.64e-05	0.000564	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CSPG4—melanoma	4.64e-05	0.000564	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—BSG—melanoma	4.64e-05	0.000564	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HPSE—melanoma	4.64e-05	0.000564	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC6A11—melanoma	4.57e-05	0.000555	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIP4K2A—melanoma	4.57e-05	0.000555	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CUBN—melanoma	4.55e-05	0.000553	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	4.53e-05	0.000551	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GPAM—melanoma	4.49e-05	0.000546	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTAP—melanoma	4.45e-05	0.00054	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.44e-05	0.00054	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CSPG4—melanoma	4.4e-05	0.000534	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.35e-05	0.000529	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.35e-05	0.000528	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS3—melanoma	4.33e-05	0.000526	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ACER3—melanoma	4.27e-05	0.000519	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SKI—melanoma	4.26e-05	0.000517	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.24e-05	0.000515	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.2e-05	0.00051	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TP53—melanoma	4.1e-05	0.000498	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.1e-05	0.000498	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.09e-05	0.000497	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.07e-05	0.000494	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PHGDH—melanoma	3.96e-05	0.000481	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LUM—melanoma	3.96e-05	0.000481	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UGT2B10—melanoma	3.9e-05	0.000474	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HPSE—melanoma	3.89e-05	0.000472	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.85e-05	0.000468	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLA2G6—melanoma	3.82e-05	0.000464	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CUBN—melanoma	3.81e-05	0.000463	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—melanoma	3.76e-05	0.000456	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.69e-05	0.000449	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SDHD—melanoma	3.68e-05	0.000447	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CSPG4—melanoma	3.68e-05	0.000447	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—BSG—melanoma	3.68e-05	0.000447	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HS3ST5—melanoma	3.63e-05	0.000441	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GPAM—melanoma	3.57e-05	0.000433	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HDAC6—melanoma	3.52e-05	0.000427	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.49e-05	0.000425	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—VCAN—melanoma	3.43e-05	0.000417	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.4e-05	0.000413	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NPPA—melanoma	3.33e-05	0.000405	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.33e-05	0.000404	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.32e-05	0.000404	CbGpPWpGaD
Nabumetone—PTGS2—Disease—VCAN—melanoma	3.25e-05	0.000395	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.25e-05	0.000395	CbGpPWpGaD
Nabumetone—PTGS2—Disease—WNT5A—melanoma	3.23e-05	0.000392	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.17e-05	0.000385	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.14e-05	0.000381	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.14e-05	0.000381	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLA2G6—melanoma	3.03e-05	0.000369	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.92e-05	0.000355	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP17A1—melanoma	2.9e-05	0.000352	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.89e-05	0.00035	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.86e-05	0.000347	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.82e-05	0.000343	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.79e-05	0.000339	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLCB4—melanoma	2.75e-05	0.000334	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GNA11—melanoma	2.73e-05	0.000332	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—VCAN—melanoma	2.72e-05	0.000331	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.7e-05	0.000328	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—FASN—melanoma	2.68e-05	0.000325	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC5A5—melanoma	2.63e-05	0.00032	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GAB2—melanoma	2.59e-05	0.000315	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIP4K2A—melanoma	2.59e-05	0.000314	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC6A11—melanoma	2.59e-05	0.000314	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.58e-05	0.000313	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GNAQ—melanoma	2.54e-05	0.000309	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CD44—melanoma	2.54e-05	0.000309	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FASN—melanoma	2.54e-05	0.000308	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTAP—melanoma	2.52e-05	0.000306	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.49e-05	0.000302	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.49e-05	0.000302	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.47e-05	0.0003	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.46e-05	0.000299	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP1B1—melanoma	2.44e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HDAC2—melanoma	2.44e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FOXO4—melanoma	2.44e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CXCR4—melanoma	2.44e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD44—melanoma	2.41e-05	0.000293	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.36e-05	0.000286	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP17A1—melanoma	2.3e-05	0.000279	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.27e-05	0.000275	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PHGDH—melanoma	2.24e-05	0.000272	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LUM—melanoma	2.24e-05	0.000272	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.24e-05	0.000272	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT3—melanoma	2.22e-05	0.00027	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HPSE—melanoma	2.2e-05	0.000267	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GNA11—melanoma	2.17e-05	0.000264	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CUBN—melanoma	2.16e-05	0.000262	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.15e-05	0.000261	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—FASN—melanoma	2.12e-05	0.000258	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC5A5—melanoma	2.09e-05	0.000254	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SDHD—melanoma	2.08e-05	0.000253	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BSG—melanoma	2.08e-05	0.000253	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CSPG4—melanoma	2.08e-05	0.000253	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPAM—melanoma	2.02e-05	0.000245	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GNAQ—melanoma	2.02e-05	0.000245	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CD44—melanoma	2.02e-05	0.000245	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCB1—melanoma	2.01e-05	0.000244	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.98e-05	0.00024	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB4—melanoma	1.96e-05	0.000239	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN2B—melanoma	1.95e-05	0.000237	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP1B1—melanoma	1.94e-05	0.000235	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD86—melanoma	1.88e-05	0.000229	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PRKCA—melanoma	1.85e-05	0.000224	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ERCC2—melanoma	1.83e-05	0.000223	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF1—melanoma	1.83e-05	0.000222	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFRA—melanoma	1.77e-05	0.000215	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCA—melanoma	1.75e-05	0.000213	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERCC2—melanoma	1.74e-05	0.000211	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLA2G6—melanoma	1.72e-05	0.000209	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAP2K2—melanoma	1.71e-05	0.000208	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.71e-05	0.000207	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TERT—melanoma	1.63e-05	0.000198	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HLA-A—melanoma	1.63e-05	0.000198	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RAC1—melanoma	1.62e-05	0.000197	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCB1—melanoma	1.59e-05	0.000194	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HIF1A—melanoma	1.56e-05	0.000189	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—VCAN—melanoma	1.54e-05	0.000187	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.52e-05	0.000184	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PRKCA—melanoma	1.47e-05	0.000178	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.46e-05	0.000177	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ERCC2—melanoma	1.45e-05	0.000177	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CG—melanoma	1.45e-05	0.000176	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—melanoma	1.42e-05	0.000172	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.41e-05	0.000171	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOTCH1—melanoma	1.4e-05	0.00017	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—melanoma	1.4e-05	0.00017	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD80—melanoma	1.37e-05	0.000167	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KIT—melanoma	1.37e-05	0.000167	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APC—melanoma	1.37e-05	0.000167	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGF—melanoma	1.36e-05	0.000165	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP17A1—melanoma	1.3e-05	0.000158	CbGpPWpGaD
Nabumetone—PTGS2—Disease—BRAF—melanoma	1.29e-05	0.000157	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.28e-05	0.000156	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CD—melanoma	1.27e-05	0.000155	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.27e-05	0.000154	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—melanoma	1.26e-05	0.000153	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GNA11—melanoma	1.23e-05	0.000149	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAP2K1—melanoma	1.21e-05	0.000147	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CD—melanoma	1.21e-05	0.000146	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.2e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FASN—melanoma	1.2e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC5A5—melanoma	1.18e-05	0.000144	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF2—melanoma	1.15e-05	0.00014	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CG—melanoma	1.15e-05	0.00014	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GNAQ—melanoma	1.14e-05	0.000139	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CD44—melanoma	1.14e-05	0.000139	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.12e-05	0.000136	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CB—melanoma	1.11e-05	0.000135	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—melanoma	1.11e-05	0.000135	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.11e-05	0.000135	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—melanoma	1.1e-05	0.000133	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP1B1—melanoma	1.1e-05	0.000133	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MDM2—melanoma	1.08e-05	0.000131	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB2—melanoma	1.07e-05	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CB—melanoma	1.05e-05	0.000128	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—melanoma	1.05e-05	0.000127	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CD—melanoma	1.01e-05	0.000123	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—melanoma	9.97e-06	0.000121	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1B—melanoma	9.86e-06	0.00012	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.66e-06	0.000117	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTEN—melanoma	9.58e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CTNNB1—melanoma	9.32e-06	0.000113	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1A—melanoma	9.1e-06	0.000111	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PTEN—melanoma	9.08e-06	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCB1—melanoma	9.02e-06	0.00011	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CB—melanoma	8.8e-06	0.000107	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PRKCA—melanoma	8.3e-06	0.000101	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ERCC2—melanoma	8.23e-06	0.0001	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—melanoma	8.12e-06	9.87e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NRAS—melanoma	8.1e-06	9.84e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK3—melanoma	7.76e-06	9.43e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PTEN—melanoma	7.61e-06	9.24e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MYC—melanoma	7.55e-06	9.17e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK1—melanoma	7.38e-06	8.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGFR—melanoma	7.38e-06	8.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KRAS—melanoma	6.97e-06	8.47e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.82e-06	8.28e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CA—melanoma	6.76e-06	8.21e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CG—melanoma	6.5e-06	7.9e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CA—melanoma	6.41e-06	7.78e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—melanoma	6.27e-06	7.62e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HRAS—melanoma	5.93e-06	7.2e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CD—melanoma	5.71e-06	6.94e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—melanoma	5.67e-06	6.89e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—melanoma	5.64e-06	6.85e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—melanoma	5.52e-06	6.71e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CA—melanoma	5.37e-06	6.52e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—melanoma	5.23e-06	6.36e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CB—melanoma	4.98e-06	6.05e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—melanoma	4.94e-06	6e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—melanoma	4.38e-06	5.32e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTEN—melanoma	4.3e-06	5.23e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CA—melanoma	3.04e-06	3.69e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—melanoma	2.48e-06	3.01e-05	CbGpPWpGaD
